These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15685486)

  • 61. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeted delivery of inhaled drugs: current challenges and future goals.
    Ganderton D
    J Aerosol Med; 1999; 12 Suppl 1():S3-8. PubMed ID: 10623339
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advances in soft mist inhalers.
    Komalla V; Wong CYJ; Sibum I; Muellinger B; Nijdam W; Chaugule V; Soria J; Ong HX; Buchmann NA; Traini D
    Expert Opin Drug Deliv; 2023; 20(8):1055-1070. PubMed ID: 37385962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Principles of metered-dose inhaler design.
    Newman SP
    Respir Care; 2005 Sep; 50(9):1177-90. PubMed ID: 16122401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers.
    Khassawneh BY; Al-Ali MK; Alzoubi KH; Batarseh MZ; Al-Safi SA; Sharara AM; Alnasr HM
    Respir Care; 2008 Mar; 53(3):324-8. PubMed ID: 18291048
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute bronchospasm from the patient's perspective: role of patient education.
    Williams D
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):193S-9S. PubMed ID: 16945066
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler.
    Rossi V; Salimäki J; Sandler C; Airaksinen M; Kauppi P
    Pulm Pharmacol Ther; 2021 Dec; 71():102077. PubMed ID: 34534672
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dry powder inhalers: which factors determine the frequency of handling errors?
    Wieshammer S; Dreyhaupt J
    Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate.
    Shrewsbury SB; Armer TA; Newman SP; Pitcairn G
    Int J Pharm; 2008 May; 356(1-2):137-43. PubMed ID: 18289809
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old.
    Kamin W; Frank M; Kattenbeck S; Moroni-Zentgraf P; Wachtel H; Zielen S
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):372-81. PubMed ID: 25844687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved inhaler handling after repeated inhalation guidance for elderly patients with bronchial asthma and chronic obstructive pulmonary disease.
    Usami O
    Medicine (Baltimore); 2022 Sep; 101(35):e30238. PubMed ID: 36107520
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An in vitro study to assess facial and ocular deposition from Respimat Soft Mist inhaler.
    Newman SP; Steed KP; Reader SJ; Pavia D; Sohal AK
    J Aerosol Med; 2007; 20(1):7-12. PubMed ID: 17388748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of a lever aid on hand strength required for using a handheld inhaler correctly.
    Nakada H; Aomori T; Mochizuki M
    Int J Pharm; 2021 Mar; 596():120249. PubMed ID: 33516902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients.
    Dal Negro RW; Povero M
    Clinicoecon Outcomes Res; 2016; 8():171-6. PubMed ID: 27274291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland.
    Tschacher A; Cadus C; Schildge S; Diedrich JP; Chhajed PN; Leuppi-Taegtmeyer AB; Leuppi JD
    Curr Med Res Opin; 2021 Nov; 37(11):2019-2033. PubMed ID: 34433362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of inhaler technique errors with a routine procedure in Portuguese community pharmacy.
    Castel-Branco MM; Fontes A; Figueiredo IV
    Pharm Pract (Granada); 2017; 15(4):1072. PubMed ID: 29317923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study.
    Erdelyi T; Lazar Z; Farkas Á; Furi P; Nagy A; Müller V
    Front Med (Lausanne); 2023; 10():1065072. PubMed ID: 37215734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of an external resistance to airflow on the inspiratory flow curve.
    de Koning JP; van der Mark TW; Coenegracht PM; Tromp TF; Frijlink HW
    Int J Pharm; 2002 Mar; 234(1-2):257-66. PubMed ID: 11839456
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Proper use and the ability to teach the use of pressurized hand-held inhalers in patients with chronic airway obstruction].
    Varsano S; Jacoby I; Garenkin M
    Harefuah; 1999 Jan; 136(1):9-14, 96. PubMed ID: 10914149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.